Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

作者: Kamakshi Sachidanandam , Vera Portik-Dobos , Aisha I. Kelly-Cobbs , Adviye Ergul

DOI: 10.1139/Y10-034

关键词: Matrix metalloproteinaseEndocrinologyEndothelin receptorBlood vesselInternal medicineDiabetes mellitusBosentanCirculatory systemBlockadeMedicineMesenteric arteries

摘要: Vascular remodeling, characterized by extracellular matrix deposition and increased media-to-lumen (M/L) ratio, contributes to the development of microvascular complications in diabetes. We have previously shown type 2 diabetic Goto–Kakizaki (GK) rats that selective ETA receptor blockade prevents medial thickening mesenteric arteries via regulation metalloproteases (MMP), whereas ETB augments this thickening. The goal study was determine effect combined on resistance vessel remodeling. Vessel structure, MMP activity, proteins were assessed control Wistar GK treated with vehicle or bosentan (100 mg/kg per day) for 4 weeks (n = 7–9 group). Bosentan completely prevented increase M/L ratio MMP-2 activity diabetes but paradoxically activation animals. Collagenase (MMP-13) protein levels significantly ...

参考文章(26)
T Masaki, Possible Role of Endothelin in Endothelial Regulation of Vascular Tone Annual Review of Pharmacology and Toxicology. ,vol. 35, pp. 235- 255 ,(1995) , 10.1146/ANNUREV.PA.35.040195.001315
Yoshiyuki Hattori, Kikuo Kasai, Tsutomu Nakamura, Tatsushi Emoto, Shin-Ichi Shimoda, Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism-clinical and Experimental. ,vol. 40, pp. 165- 169 ,(1991) , 10.1016/0026-0495(91)90168-V
R. V. Farese, M. L. Standaert, K. Yamada, L. C. Huang, C. Zhang, D. R. Cooper, Z. Wang, Y. Yang, S. Suzuki, T. Toyota, Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 11040- 11044 ,(1994) , 10.1073/PNAS.91.23.11040
Vera Portik-Dobos, Alex K. Harris, Weiwei Song, Jimmie Hutchinson, Maribeth H. Johnson, John D. Imig, David M. Pollock, Adviye Ergul, Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 290, ,(2006) , 10.1152/AJPREGU.00300.2005
Sheng-Qian Wu, Rob L Hopfner, J Robert McNeill, Thomas W Wilson, Venkat Gopalakrishnan, Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat Cardiovascular Research. ,vol. 45, pp. 994- 1000 ,(2000) , 10.1016/S0008-6363(99)00417-4
Nobuyuki Murakoshi, Takashi Miyauchi, Yoshihiko Kakinuma, Takashi Ohuchi, Katsutoshi Goto, Masashi Yanagisawa, Iwao Yamaguchi, Vascular Endothelin-B Receptor System In Vivo Plays a Favorable Inhibitory Role in Vascular Remodeling After Injury Revealed by Endothelin-B Receptor–Knockout Mice Circulation. ,vol. 106, pp. 1991- 1998 ,(2002) , 10.1161/01.CIR.0000032004.56585.2A
K. Takahashi, M. A. Ghatei, H. -C. Lam, D. J. O'Halloran, S. R. Bloom, Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. ,vol. 33, pp. 306- 310 ,(1990) , 10.1007/BF00403325